Houdini Bio: Funding, Investors & Team (Sep 2026)
Houdini Bio develops computational synthetic biology tools that redesign DNA sequences and gene constructs for more effective genetic medicines. The company focuses on re-engineering and optimizing DNA constructs to address performance and scalability constraints in complex therapeutics. Its technology applies computational biology methods to improve expression characteristics and manufacturing properties of genetic medicine assets. Houdini Bio works with partners developing next-generation genetic therapies who seek to enhance therapeutic index and production output. Its core offering centers on a DNA redesign engine that enables systematic exploration of sequence space to generate constructs with improved functional profiles. The company positions its capabilities for use in biopharmaceutical research and development workflows for genetic medicines. Houdini Bio concentrates on supporting organizations working on advanced genetic therapeutics that require improved construct design and manufacturability.
Houdini Bio has raised $1.9M across 1 funding round on record, the most recent a Pre-Seed of $1.9M announced in Jun 2026.
That round is below the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Houdini Bio Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Houdini Bio Funding Rounds
Houdini Bio Founders and Leadership Team
No contact details are on record for this team yet.
Houdini Bio Funding Compared to Other Artificial Intelligence Startups
Houdini Bio's latest round of $1.9M is below the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Houdini Bio in Artificial Intelligence and London
Companies Similar to Houdini Bio
Stability AI is developing open AI resources that enable us to maximize our capabilities. We create and…
Callosum provides data analytics, artificial intelligence, and digital engineering services for data…
Medly AI is an advanced tutor that is able to support students in multiple languages through the use of…
Mindgard is an AI security company that assists businesses in safeguarding their AI models against cyber…
Edgify is a developer of a predictive personalization technology used to analyze a user's photos on their…
The AI agents provided by Finster AI possess the ability to comprehend, evaluate, and incorporate various…
Malted AI is a company that designs a low-code platform that allows businesses to create and launch…
OLIX designs and manufactures optical processors that use light-based circuits to accelerate artificial…
Qureight is a company specializing in imaging analytics, with a goal of enhancing its analytical platform to…
Greyparrot is the leading AI waste analytics platform for the circular economy. We are on a mission to…
Founded by Dr. Sam Tukra and Callum Adamson (who have been working together since 2019) in 2023 to solve the…
1001 AI is a deep-tech artificial intelligence startup that develops AI infrastructure and…
Houdini Bio Funding FAQs
What does Houdini Bio do?
Houdini Bio develops computational synthetic biology tools that redesign DNA sequences and gene constructs for more effective genetic medicines. The company focuses on re-engineering and optimizing DNA constructs to address performance and scalability constraints in complex therapeutics. Its technology applies computational biology methods to improve expression characteristics and manufacturing properties of genetic medicine assets. Houdini Bio works with partners developing next-generation genetic therapies who seek to enhance therapeutic index and production output. Its core offering centers on a DNA redesign engine that enables systematic exploration of sequence space to generate constructs with improved functional profiles. The company positions its capabilities for use in biopharmaceutical research and development workflows for genetic medicines. Houdini Bio concentrates on supporting organizations working on advanced genetic therapeutics that require improved construct design and manufacturability.
How much funding has Houdini Bio raised?
Houdini Bio has raised $1.9M across 1 round on record. The most recent is a Pre-Seed of $1.9M announced in Jun 2026.
When did Houdini Bio last raise funding?
Houdini Bio's most recent funding round on record is a Pre-Seed of $1.9M, announced in Jun 2026.
Who founded Houdini Bio?
FundedIQ lists Lee Dunham (Founder) at Houdini Bio.
Where is Houdini Bio headquartered?
Houdini Bio is based in London, England, United Kingdom.
How many employees does Houdini Bio have?
Houdini Bio is in the 1-10 employee band.
How does Houdini Bio's funding compare to other Artificial Intelligence startups?
Houdini Bio's latest round of $1.9M is below the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.
About FundedIQ's Houdini Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Houdini Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.